Sutro Biopharma Inc - ESG Rating & Company Profile powered by AI
Full Sustainability assessment of Sutro Biopharma Inc are reached by signing in. The webpage of Sutro Biopharma Inc was assembled by All Street Sevva using leading NLP. This report of Sutro Biopharma Inc leverages intelligence from across the web and also from public disclosures by Sutro Biopharma Inc.
Sutro Biopharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Sutro Biopharma Inc | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sutro Biopharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Sutro Biopharma Inc report the average age of the workforce?
Sign up for free to unlockDoes Sutro Biopharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Sutro Biopharma Inc offer flexible work?
Sign up for free to unlockDoes Sutro Biopharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sutro Biopharma Inc conduct supply chain audits?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sutro Biopharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose water use targets?
Sign up for free to unlockDoes Sutro Biopharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Sutro Biopharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Sutro Biopharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sutro Biopharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sutro Biopharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sutro Biopharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sutro Biopharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose its waste policy?
Sign up for free to unlockDoes Sutro Biopharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose energy use targets?
Sign up for free to unlockDoes Sutro Biopharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sutro Biopharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sutro Biopharma Inc
These potential risks are based on the size, segment and geographies of the company.
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.